Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
2.555
+0.225 (9.66%)
Sep 18, 2025, 11:37 AM EDT - Market open
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $41.53 million as of September 18, 2025. Its market cap has decreased by -87.39% in one year.
Market Cap
41.53M
Enterprise Value
515.26K
1-Year Change
-87.39%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $41.53M, a decrease of -66.17%. That is a compound annual growth rate of -17.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 37.87M | -88.19% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.85B |
| Johnson & Johnson | 427.24B |
| AbbVie | 390.83B |
| UnitedHealth Group | 308.29B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.99B |